NCT05096442View on ClinicalTrials.gov

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

NACompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

June 28, 2023

Study Completion Date

November 21, 2023

Conditions

Coronary Artery Disease

Interventions

DEVICE

GENOSS® DCB

Drug Coated Balloon

DEVICE

SeQuent® Please NEO

Drug Coated Balloon

Trial Locations (1)

Unknown

Ulsan University Hospital, Ulsan

All Listed Sponsors

lead

Genoss Co., Ltd.

INDUSTRY

NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions | Biotech Hunter | Biotech Hunter